SELLAS Life Sciences Group, Inc. (SLS)
5.465
+0.44
(+8.65%)
USD |
NASDAQ |
Mar 13, 12:52
SELLAS Life Sciences Group EPS Diluted (Quarterly) : -0.0626 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0054 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| GT Biopharma, Inc. | -4.413 |
| ADMA Biologics, Inc. | 0.2025 |
| Lyell Immunopharma, Inc. | -2.126 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.791M |
| Total Expenses (Quarterly) | 6.791M |
| Enterprise Value | 812.70M |
| Earnings Yield | -5.25% |
| Normalized Earnings Yield | -5.250 |